img

Global IVD Antibodies Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global IVD Antibodies Market Research Report 2024

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.
According to MRAResearch’s new survey, global IVD Antibodies market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole IVD Antibodies market research.
Key companies engaged in the IVD Antibodies industry include Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest and Abbott, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of IVD Antibodies were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole IVD Antibodies market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global IVD Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott
Segment by Type
Cardiac Markers
Tumor Markers
Kidney Injury Markers

Segment by Application


Hospital
Specialty Clinic
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The IVD Antibodies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Antibodies Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cardiac Markers
1.2.3 Tumor Markers
1.2.4 Kidney Injury Markers
1.3 Market by Application
1.3.1 Global IVD Antibodies Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Diagnostic Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Antibodies Market Perspective (2018-2033)
2.2 IVD Antibodies Growth Trends by Region
2.2.1 Global IVD Antibodies Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 IVD Antibodies Historic Market Size by Region (2018-2023)
2.2.3 IVD Antibodies Forecasted Market Size by Region (2024-2033)
2.3 IVD Antibodies Market Dynamics
2.3.1 IVD Antibodies Industry Trends
2.3.2 IVD Antibodies Market Drivers
2.3.3 IVD Antibodies Market Challenges
2.3.4 IVD Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Antibodies Players by Revenue
3.1.1 Global Top IVD Antibodies Players by Revenue (2018-2023)
3.1.2 Global IVD Antibodies Revenue Market Share by Players (2018-2023)
3.2 Global IVD Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Antibodies Revenue
3.4 Global IVD Antibodies Market Concentration Ratio
3.4.1 Global IVD Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Antibodies Revenue in 2022
3.5 IVD Antibodies Key Players Head office and Area Served
3.6 Key Players IVD Antibodies Product Solution and Service
3.7 Date of Enter into IVD Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Antibodies Breakdown Data by Type
4.1 Global IVD Antibodies Historic Market Size by Type (2018-2023)
4.2 Global IVD Antibodies Forecasted Market Size by Type (2024-2033)
5 IVD Antibodies Breakdown Data by Application
5.1 Global IVD Antibodies Historic Market Size by Application (2018-2023)
5.2 Global IVD Antibodies Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America IVD Antibodies Market Size (2018-2033)
6.2 North America IVD Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America IVD Antibodies Market Size by Country (2018-2023)
6.4 North America IVD Antibodies Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD Antibodies Market Size (2018-2033)
7.2 Europe IVD Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe IVD Antibodies Market Size by Country (2018-2023)
7.4 Europe IVD Antibodies Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Antibodies Market Size (2018-2033)
8.2 Asia-Pacific IVD Antibodies Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific IVD Antibodies Market Size by Region (2018-2023)
8.4 Asia-Pacific IVD Antibodies Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVD Antibodies Market Size (2018-2033)
9.2 Latin America IVD Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America IVD Antibodies Market Size by Country (2018-2023)
9.4 Latin America IVD Antibodies Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Antibodies Market Size (2018-2033)
10.2 Middle East & Africa IVD Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa IVD Antibodies Market Size by Country (2018-2023)
10.4 Middle East & Africa IVD Antibodies Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam IVD Antibodies Introduction
11.1.4 Abcam Revenue in IVD Antibodies Business (2018-2023)
11.1.5 Abcam Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific IVD Antibodies Introduction
11.2.4 Thermo Fisher Scientific Revenue in IVD Antibodies Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Rockland Immunochemicals
11.3.1 Rockland Immunochemicals Company Detail
11.3.2 Rockland Immunochemicals Business Overview
11.3.3 Rockland Immunochemicals IVD Antibodies Introduction
11.3.4 Rockland Immunochemicals Revenue in IVD Antibodies Business (2018-2023)
11.3.5 Rockland Immunochemicals Recent Development
11.4 GenScript
11.4.1 GenScript Company Detail
11.4.2 GenScript Business Overview
11.4.3 GenScript IVD Antibodies Introduction
11.4.4 GenScript Revenue in IVD Antibodies Business (2018-2023)
11.4.5 GenScript Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories IVD Antibodies Introduction
11.5.4 Bio-Rad Laboratories Revenue in IVD Antibodies Business (2018-2023)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 SDIX
11.6.1 SDIX Company Detail
11.6.2 SDIX Business Overview
11.6.3 SDIX IVD Antibodies Introduction
11.6.4 SDIX Revenue in IVD Antibodies Business (2018-2023)
11.6.5 SDIX Recent Development
11.7 MEDICAL & BIOLOGICAL LABORATORIES
11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Detail
11.7.2 MEDICAL & BIOLOGICAL LABORATORIES Business Overview
11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Introduction
11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2018-2023)
11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Recent Development
11.8 HyTest
11.8.1 HyTest Company Detail
11.8.2 HyTest Business Overview
11.8.3 HyTest IVD Antibodies Introduction
11.8.4 HyTest Revenue in IVD Antibodies Business (2018-2023)
11.8.5 HyTest Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott IVD Antibodies Introduction
11.9.4 Abbott Revenue in IVD Antibodies Business (2018-2023)
11.9.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global IVD Antibodies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cardiac Markers
Table 3. Key Players of Tumor Markers
Table 4. Key Players of Kidney Injury Markers
Table 5. Global IVD Antibodies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global IVD Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global IVD Antibodies Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global IVD Antibodies Market Share by Region (2018-2023)
Table 9. Global IVD Antibodies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global IVD Antibodies Market Share by Region (2024-2033)
Table 11. IVD Antibodies Market Trends
Table 12. IVD Antibodies Market Drivers
Table 13. IVD Antibodies Market Challenges
Table 14. IVD Antibodies Market Restraints
Table 15. Global IVD Antibodies Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global IVD Antibodies Market Share by Players (2018-2023)
Table 17. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibodies as of 2022)
Table 18. Ranking of Global Top IVD Antibodies Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by IVD Antibodies Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players IVD Antibodies Product Solution and Service
Table 22. Date of Enter into IVD Antibodies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global IVD Antibodies Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global IVD Antibodies Revenue Market Share by Type (2018-2023)
Table 26. Global IVD Antibodies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global IVD Antibodies Revenue Market Share by Type (2024-2033)
Table 28. Global IVD Antibodies Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global IVD Antibodies Revenue Market Share by Application (2018-2023)
Table 30. Global IVD Antibodies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global IVD Antibodies Revenue Market Share by Application (2024-2033)
Table 32. North America IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America IVD Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America IVD Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe IVD Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe IVD Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific IVD Antibodies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific IVD Antibodies Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific IVD Antibodies Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America IVD Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America IVD Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa IVD Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa IVD Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 47. Abcam Company Detail
Table 48. Abcam Business Overview
Table 49. Abcam IVD Antibodies Product
Table 50. Abcam Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific IVD Antibodies Product
Table 55. Thermo Fisher Scientific Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Rockland Immunochemicals Company Detail
Table 58. Rockland Immunochemicals Business Overview
Table 59. Rockland Immunochemicals IVD Antibodies Product
Table 60. Rockland Immunochemicals Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 61. Rockland Immunochemicals Recent Development
Table 62. GenScript Company Detail
Table 63. GenScript Business Overview
Table 64. GenScript IVD Antibodies Product
Table 65. GenScript Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 66. GenScript Recent Development
Table 67. Bio-Rad Laboratories Company Detail
Table 68. Bio-Rad Laboratories Business Overview
Table 69. Bio-Rad Laboratories IVD Antibodies Product
Table 70. Bio-Rad Laboratories Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 71. Bio-Rad Laboratories Recent Development
Table 72. SDIX Company Detail
Table 73. SDIX Business Overview
Table 74. SDIX IVD Antibodies Product
Table 75. SDIX Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 76. SDIX Recent Development
Table 77. MEDICAL & BIOLOGICAL LABORATORIES Company Detail
Table 78. MEDICAL & BIOLOGICAL LABORATORIES Business Overview
Table 79. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product
Table 80. MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 81. MEDICAL & BIOLOGICAL LABORATORIES Recent Development
Table 82. HyTest Company Detail
Table 83. HyTest Business Overview
Table 84. HyTest IVD Antibodies Product
Table 85. HyTest Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 86. HyTest Recent Development
Table 87. Abbott Company Detail
Table 88. Abbott Business Overview
Table 89. Abbott IVD Antibodies Product
Table 90. Abbott Revenue in IVD Antibodies Business (2018-2023) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Antibodies Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global IVD Antibodies Market Share by Type: 2022 VS 2033
Figure 3. Cardiac Markers Features
Figure 4. Tumor Markers Features
Figure 5. Kidney Injury Markers Features
Figure 6. Global IVD Antibodies Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global IVD Antibodies Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Specialty Clinic Case Studies
Figure 10. Diagnostic Center Case Studies
Figure 11. Others Case Studies
Figure 12. IVD Antibodies Report Years Considered
Figure 13. Global IVD Antibodies Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global IVD Antibodies Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global IVD Antibodies Market Share by Region: 2022 VS 2033
Figure 16. Global IVD Antibodies Market Share by Players in 2022
Figure 17. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibodies as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by IVD Antibodies Revenue in 2022
Figure 19. North America IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America IVD Antibodies Market Share by Country (2018-2033)
Figure 21. United States IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe IVD Antibodies Market Share by Country (2018-2033)
Figure 25. Germany IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific IVD Antibodies Market Share by Region (2018-2033)
Figure 33. China IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America IVD Antibodies Market Share by Country (2018-2033)
Figure 41. Mexico IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa IVD Antibodies Market Share by Country (2018-2033)
Figure 45. Turkey IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia IVD Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Abcam Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 49. Rockland Immunochemicals Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 50. GenScript Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 52. SDIX Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 53. MEDICAL & BIOLOGICAL LABORATORIES Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 54. HyTest Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in IVD Antibodies Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed